A computational investigation of pathways for ex vivo differentiation and dysfunction of healthy and patient T cells
Adoptive T cell therapy is a promising field in cancer immunotherapy that leverages the natural ability of T cells to target and kill cancer cells. A crucial step in this therapy involves the ex vivo expansion of memory-like and effector-like T cells, but limiting their differentiation into exhaustion-associated phenotypes remains a challenge. Mathematical model-informed strategies to optimise T…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
